Using blood markers for Alzheimer disease in clinical practice?

Neurology

Volumn 79, Issue 9, 2012, Pages 846-847

  O'Bryant, Sid E ^a  

^a University of North Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ALZHEIMER DISEASE; BIOINFORMATICS; BLOOD; CLINICAL PRACTICE; COGNITIVE DEFECT; DIAGNOSTIC ACCURACY; EDITORIAL; ETHNICITY; HUMAN; NEUROIMAGING; PRIORITY JOURNAL; RACE;

EID: 84866093753     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318266fd21     Document Type: Editorial

References (8)

1. Ray S, Britschgi M, Herbert C, et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 2007;13:1359-1362.
2. Soares HD, Chen Y, Sabbagh M, Rohrer A, Schrijvers E, Breteler M. Identifying early markers of Alzheimer's disease using quantative multiplex proteomic immunoassay panels. Ann NY Acad Sci 2009;1180:56-67.
3. O'Bryant SE, Xiao G, Barber R, et al. A serum proteinbased algorithm for the detection of Alzheimer's disease. Arch Neurol 2010;67:1077-1081.
4. Laske C, Leyhe T, Strandsky E, Hoffmann N, Fallgatter A, Dietzch J. Identification of a blood-based biomarker panel for classification of Alzheimer's disease. Int J Neuropsychopharmacol 2011;14:1147-1155.
5. Reedy MM, Wilson R, Wilson J, et al. Identification of candidate IgG biomarkers for Alzheimer's disease via combinatorial library screening. Cell 2011;144:132-142.
6. O'Bryant SE, Xiao G, Barber R, Huebinger R, Wilhelmsen K, Edwards M. A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI. PLoS One 2011;6:e28092.
7. Hu WT, Holtzman DM, Fagan AM, et al. Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology 2012;79:897-905.
8. Breteler MB. Mapping out biomarkers for Alzheimer's disease. JAMA 2011;305:304-305.